Health & Fitness

According to FutureWise analysis, the Huntington's disease genetic testing market in 2025 is US$24.05 million, and is expected to reach US$32.18 million by 2033 at a CAGR of 3.71%.  The market for genetic testing related to Huntington's disease is experiencing significant growth, driven by advancements in molecular diagnostics and increased awareness of the importance of predictive genetic testing, particularly for individuals with a family history of the disease. This vital test detects CAG trinucleotide repeat expansions in the HTT gene, with 40 or more repeats confirming the presence of this autosomal dominant neurodegenerative disorder. Additionally, the rising popularity of preimplantation genetic testing and prenatal screening options is further contributing to market growth, especially in regions with well-established genetic counseling services.  North America is leading this trend, benefitting from comprehensive healthcare coverage for genetic ... Continue reading →

According to FutureWise analysis the market for hyaluronic acid dermal filler in 2025 is US$ 4.43 billion, and is expected to reach US$ 9.51 billion by 2033 at a CAGR of 10.02%. Strong growth in the market is fueled by rising demand for minimally invasive aesthetic procedures and increased awareness of facial rejuvenation treatments. Advancements in filler formulations for longer-lasting, natural results and a growing base of trained professionals further support this trend, along with broader acceptance of cosmetic treatments across various age groups. Hyaluronic acid dermal fillers are popular injectable treatments in the field of aesthetic medicine, intended to restore facial volume, smooth out wrinkles, and enhance facial contours with minimal invasiveness. Hyaluronic acid (HA) is a naturally occurring biomolecule within the human body, primarily located in the dermis, connective tissues, and ocular structures. It plays a vital role in maintaining hydration, elasticity, and the ... Continue reading →

According to FutureWise analysis, the hyaluronic acid-based dermal fillers market in 2025 is US$4.46 billion, and is expected to reach US$9.57 billion by 2033 at a CAGR of 10.01%.   The hyaluronic acid-based dermal fillers market is experiencing a thrilling transformation, fueled by an ever-growing interest in minimally invasive beauty treatments. With social media shaping modern beauty standards, people of all genders are increasingly eager to explore the world of cosmetic enhancements. This surge in popularity is pushing the demand for these fillers to unprecedented levels. So, what makes hyaluronic acid fillers so irresistible? For starters, their incredible biocompatibility ensures that they seamlessly integrate into the skin, while their reversibility offers peace of mind for those hesitant about commitment. Plus, they deliver stunning, natural-looking results for everything from smoothing facial wrinkles to restoring lost volume and enhancing lips.  ... Continue reading →

According to FutureWise analysis the market for Hybrid Imaging in 2025 is US$ 8.52 billion, and is expected to reach US$ 12.49 billion by 2033 at a CAGR of 4.90%. This growth is fueled by the rising demand for early and precise disease diagnosis in oncology, cardiology, and neurology. Advances in imaging technology, such as better detectors and reduced radiation exposure, are boosting clinical adoption. The emphasis on personalized medicine and enhanced diagnostic efficiency is also driving market expansion. Hybrid imaging involves the integration of advanced medical imaging technologies that combine two or more imaging modalities into a single system. This approach provides both anatomical and functional information during a single examination. By leveraging the unique strengths of different imaging techniques, hybrid imaging contributes to more accurate diagnoses, enhanced disease characterization, and improved treatment planning. Common examples of hybrid imaging systems are ... Continue reading →

Hydraulic stretchers, also known as pneumatic stretchers, are equipped with an attached hydraulic system that controls their movement. These stretchers are primarily used to transport patients lying down or, in some cases, sitting. They are commonly found in emergency departments, trauma centers, and post-anesthesia care units. The main function of these stretchers is to facilitate the transportation of patients between different units within hospitals and treatment centers. They can also be utilized outdoors, particularly by ambulance personnel, to move patients to medical facilities. In medical emergencies, patients are often transported to the hospital's emergency room via ambulance, especially if they are unconscious due to trauma, cardiac arrest, strokes, or other critical conditions. Rapidly transferring patients from the ambulance to the operating room or intensive care unit is crucial in such situations. Emergency trolleys assist in this mobility, ideally supporting ... Continue reading →

According to FutureWise analysis the market for hybrid operating rooms in 2025 is US$ 1.56 billion, and is expected to reach US$ 3.49 billion by 2033 at a CAGR of 10.59%. The strong growth in the hybrid operating rooms market is driven by rising demand for minimally invasive and image-guided surgeries in cardiovascular, neurological, and orthopedic fields. Increased hospital investments in advanced surgical infrastructure and a focus on enhancing surgical efficiency, patient safety, and clinical outcomes are also accelerating adoption. Hybrid operating rooms (hybrid ORs) represent a significant advancement in surgical environments by merging a fully equipped operating theater with state-of-the-art medical imaging technologies. This integration allows for both open and minimally invasive surgical procedures to be conducted in the same space. Hybrid ORs incorporate real-time imaging systems, such as fixed C-arms, CT scanners, and advanced fluoroscopy, alongside surgical equipment, ... Continue reading →

According to FutureWise analysis, the Hydrocephalus market in 2025 is US$8.15 billion, and is expected to reach US$11.76 billion by 2033 at a CAGR of 4.69%.  The hydrocephalus market  is experiencing significant growth due to several key factors. The increasing prevalence of congenital hydrocephalus, a rise in traumatic brain injuries, and a growing elderly population more susceptible to normal pressure hydrocephalus are all driving demand for effective treatments. Ventriculoperitoneal (VP) shunts have long been recognized as the gold standard for managing this condition, but innovative solutions such as programmable shunt valves and endoscopic third ventriculostomy (ETV) are quickly gaining popularity. These advancements promise improved patient outcomes and fewer revision surgeries. Moreover, cutting-edge technologies are transforming shunt systems with features like anti-siphon devices and infection-resistant materials, significantly enhancing patient safety and ... Continue reading →

According to FutureWise analysis the Hydantoin Anticonvulsants Market in 2025 is US$ 220.04 million, and is expected to reach US$ 329.12 million by 2033 at a CAGR of 5.16%. The growth is driven by the use of hydantoin-based drugs for epilepsy and seizure disorders, along with the rising prevalence of neurological conditions and improved diagnosis rates. Sustained demand in developed and emerging markets, along with ongoing research to enhance drug safety and effectiveness, supports long-term adoption. The growth of the hydantoin anticonvulsants market is being driven by an increase in research and development activities within the pharmaceutical sector. This trend is expected to significantly benefit the market's expansion. Additionally, the rising rate of drug approvals and new product launches is likely to further accelerate market growth. Hydantoins are a class of pharmaceuticals widely utilized for the treatment of seizures, functioning as anticonvulsant or antiepileptic drugs. ... Continue reading →

According to FutureWise analysis, the Hydrocephalus Shunts Market in 2025 is US$512.61 million, and is expected to reach US$749.38 million by 2033 at a CAGR of 4.86%.   The hydrocephalus shunts market is on the rise, and it’s an exciting time for innovation! Groundbreaking technological advancements, especially in programmable valve systems, are transforming the industry. These state-of-the-art devices not only allow for non-invasive adjustments to pressure but also significantly reduce the need for revision surgeries—truly a game-changer for patients and their families. Another remarkable development is the increasing adoption of antimicrobial-coated shunts. These specially engineered devices are proving to be a game-changer in the fight against infections, which have long been a common complication of shunt procedures. The growing prevalence of pediatric hydrocephalus cases, paired with cutting-edge diagnostic imaging techniques, is making it ... Continue reading →

Hydrochlorothiazide is classified as a thiazide diuretic, commonly referred to as a "water pill." It functions by preventing the body from retaining excessive salt, thereby aiding in fluid management. By increasing urine production, it helps to lower blood pressure through a reduction of fluid volume within the body. Hydrochlorothiazide is often prescribed to manage edema, which is the accumulation of excess fluid in bodily tissues. Conditions such as heart disease, kidney disease, and liver disease can contribute to the development of edema. Maintaining healthy blood pressure is crucial, as elevated levels put additional strain on the heart and arteries. Long-term cardiovascular issues can lead to compromised blood flow, potentially resulting in severe health events like strokes, heart failure, and kidney failure. Lower blood pressure can mitigate the risk of these complications. In patients with elevated calcium levels in their blood, hydrochlorothiazide is also utilized ... Continue reading →